Nothing Special   »   [go: up one dir, main page]

GB9707041D0 - Inhibitors of the interaction between p53 and mdm2 - Google Patents

Inhibitors of the interaction between p53 and mdm2

Info

Publication number
GB9707041D0
GB9707041D0 GBGB9707041.1A GB9707041A GB9707041D0 GB 9707041 D0 GB9707041 D0 GB 9707041D0 GB 9707041 A GB9707041 A GB 9707041A GB 9707041 D0 GB9707041 D0 GB 9707041D0
Authority
GB
United Kingdom
Prior art keywords
mdm2
inhibitors
interaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9707041.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Cancer Research Campaign Technology Ltd
Original Assignee
Ciba Geigy AG
Novartis AG
Cancer Research Campaign Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Novartis AG, Cancer Research Campaign Technology Ltd filed Critical Ciba Geigy AG
Priority to GBGB9707041.1A priority Critical patent/GB9707041D0/en
Publication of GB9707041D0 publication Critical patent/GB9707041D0/en
Priority to EP97935511A priority patent/EP0958305B1/en
Priority to AU38479/97A priority patent/AU3847997A/en
Priority to DE69738754T priority patent/DE69738754D1/en
Priority to JP10504775A priority patent/JP2001500365A/en
Priority to CA002259149A priority patent/CA2259149A1/en
Priority to NZ333609A priority patent/NZ333609A/en
Priority to US09/214,371 priority patent/US7083983B2/en
Priority to AT97935511T priority patent/ATE397621T1/en
Priority to PCT/EP1997/003549 priority patent/WO1998001467A2/en
Priority to US10/927,262 priority patent/US20050137137A1/en
Pending legal-status Critical Current

Links

GBGB9707041.1A 1996-07-05 1997-04-07 Inhibitors of the interaction between p53 and mdm2 Pending GB9707041D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB9707041.1A GB9707041D0 (en) 1997-04-07 1997-04-07 Inhibitors of the interaction between p53 and mdm2
PCT/EP1997/003549 WO1998001467A2 (en) 1996-07-05 1997-07-04 Inhibitors of the interaction between p53 and mdm2
JP10504775A JP2001500365A (en) 1996-07-05 1997-07-04 Inhibitor of the interaction between P53 and MDM2
AU38479/97A AU3847997A (en) 1996-07-05 1997-07-04 Inhibitors of the interaction between P53 and MDM2
DE69738754T DE69738754D1 (en) 1996-07-05 1997-07-04 HEMMER OF INTERACTION BETWEEN P53 AND MDM2
EP97935511A EP0958305B1 (en) 1996-07-05 1997-07-04 Inhibitions of the interaction between p53 and mdm2
CA002259149A CA2259149A1 (en) 1996-07-05 1997-07-04 Inhibitors of the interaction between p53 and mdm2
NZ333609A NZ333609A (en) 1996-07-05 1997-07-04 Peptide inhibitors of the interaction between P35 and MDM2 and the treatment of tumor cells
US09/214,371 US7083983B2 (en) 1996-07-05 1997-07-04 Inhibitors of the interaction between P53 and MDM2
AT97935511T ATE397621T1 (en) 1996-07-05 1997-07-04 INHIBITORS OF INTERACTION BETWEEN P53 AND MDM2
US10/927,262 US20050137137A1 (en) 1996-07-05 2004-08-25 Inhibitors of the Interaction between p53 and MDM2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9707041.1A GB9707041D0 (en) 1997-04-07 1997-04-07 Inhibitors of the interaction between p53 and mdm2

Publications (1)

Publication Number Publication Date
GB9707041D0 true GB9707041D0 (en) 1997-05-28

Family

ID=10810426

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9707041.1A Pending GB9707041D0 (en) 1996-07-05 1997-04-07 Inhibitors of the interaction between p53 and mdm2

Country Status (1)

Country Link
GB (1) GB9707041D0 (en)

Similar Documents

Publication Publication Date Title
EP1009415A4 (en) INHIBITORS OF $g(b)-LACTAMASES AND USES THEREFOR
EP1037635A4 (en) Compounds and methods
AU6983198A (en) Retaining wall block and wall construction
PL334846A1 (en) Sulphamidic inhibitors of metaloproteases
AU7970998A (en) Cover folder and method of constructing the same
HUP0100184A3 (en) Substituted 2-benzylamino-2-phenyl-acetamide compounds and pharmaceuticals comprising them
HUP0000719A3 (en) Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same
GB9702354D0 (en) Compounds and their use
HUP0000729A3 (en) Novel amide compounds and drugs containing the same
GB9704349D0 (en) Levobupivacaine and its use
AU8695298A (en) Compounds and uses thereof
HUP9800146A3 (en) Thalidomide-derivatives and use of them
AU6119398A (en) Phenylpropenone compounds and medicines containing the same
EP1032559A4 (en) Aminoalkylphenol derivatives and related compounds
AU6640498A (en) Package and method of making the same
GB9714276D0 (en) Peptides and related compounds
ZA988492B (en) Substituted tetrahydro-naphthalenes and analogous compounds
PL325270A1 (en) Coating compound and application thereof
EP0998578A4 (en) Sel-10 AND USES THEREOF
EP0819800A3 (en) Metallic element for ceilings and walls
GB9707041D0 (en) Inhibitors of the interaction between p53 and mdm2
PL341293A1 (en) Beta-lypothropin and application thereof
GB9704370D0 (en) Levobupivacaine and its use
AU8693198A (en) Compounds and uses thereof
EP1038021A4 (en) Compounds and methods for the inhibition of protein-protein interactions